CAS Number: 118292-40-3
Retinoid related drug. Transcutaneous absorption miimal (< 3%). Caution if applied in > 20% of the body surface area.
CAS Number: 118292-40-3
Topical tazarotene has not been studied during breastfeeding. Tazarotene is not contraindicated during breastfeeding and if tazarotene is required by the mother, it is not a reason to discontinue breastfeeding. However, some experts feel it should not be used on greater than 20% of the body surface area while nursing because of possible absorption.[1] If tazarotene is used, ensure that the infant's skin does not come into direct contact with the areas of maternal skin that have been treated and the infant does not ingest the product from the mother's skin.
During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Tazorac | Tazarotene Gel then you shall inform your doctor, But you should not be worried too much as Tazorac | Tazarotene Gel comes in category of low risk drug.
Though Tazorac | Tazarotene Gel dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.
Not much
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week